Eric Broyles

Eric Broyles has a diverse work experience that spans over several industries and roles. Eric is currently the Founder & CEO of Nanocan Therapeutics Corporation, a biotechnology company focused on developing nanotechnology-based innovations for therapeutic medicines. Prior to this, Eric was the Founder & Chairman of the Board at ExpertConnect Litigation Support, where they helped law firms and in-house legal departments find and retain expert witnesses using advanced technology. Eric also served as a Board Member at Universal PharmaSystems, Inc., a company offering contract pharmaceutical packaging and manufacturing services. Eric's entrepreneurial ventures also include being the Founder & Shareholder of ExpertConnect, a network of subject matter experts providing insights to institutional investors and corporations. Eric co-founded and served as a Board Member of megree, Inc., a social business software company that licenses its technology for corporations, political campaigns, and non-profit groups. Eric has also held positions at Gerson Lehrman Group, AOL, and Skadden, Arps, Slate, Meagher & Flom LLP and Affiliates, where they gained experience in fields such as directorship, transactional law, and corporate technology transactions. Eric started their career as a Judicial Law Clerk for the Chief Judge of the United States Court of Appeals for the Eleventh Circuit. In addition to their professional endeavors, Eric has also served as a Member of the Board of Trustees of the University of Cincinnati Foundation.

Eric Broyles attended the University of Cincinnati from 1987 to 1992, where they earned a Bachelor of Business Administration (BBA) degree. During this time, their field of study focused on marketing and management. Following their undergraduate studies, they continued their education at the University of Virginia School of Law from 1992 to 1995, obtaining a Juris Doctor (J.D.) degree with a specialization in Law.